Significance	NN
of	IN
elevated	JJ
procollagen-III-peptide	NN
and	CC
transforming-growth-factor-beta	NN
levels	NNS
of	IN
bronchoalveolar	JJ
lavage	NN
fluids	NNS
from	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
patients	NNS
.	.

Although	IN
both	DT
procollagen	NN
III	CD
aminopeptide	NN
(	(
P-III-P	NN
)	)
and	CC
transforming-growth-factor-beta	NN
(	(
TGF-beta	NN
)	)
are	VBP
reported	VBN
to	TO
be	VB
present	JJ
in	IN
lung	NN
tissue	NN
and/or	CC
elevated	JJ
in	IN
bronchoalveolar	JJ
lavage	NN
fluid	NN
(	(
BALF	NN
)	)
from	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
patients	NNS
,	,
we	PRP
have	VBP
little	JJ
knowledge	NN
concerning	VBG
the	DT
clinical	JJ
significance	NN
of	IN
elevated	JJ
P-III-P	NN
and	CC
TGF-beta	NN
levels	NNS
in	IN
BALF	NN
.	.

Using	VBG
a	DT
radioimmunoassay	NN
,	,
we	PRP
measured	VBD
P-III-P	NN
and	CC
TGF-beta	NN
in	IN
BALF	NN
from	IN
48	CD
IPF	NN
patients	NNS
(	(
16F	NN
and	CC
32M	NN
,	,
59	CD
+	CC
/	:
-	:
2	CD
years	NNS
,	,
mean	NN
+	CC
/	:
-	:
S.E.	NN
)	)
who	WP
received	VBD
BAL	NN
in	IN
our	PRP$
clinic	NN
over	IN
the	DT
past	JJ
13	CD
years	NNS
before	IN
glucocorticosteroid	NN
treatment	NN
.	.

Among	IN
them	PRP
,	,
we	PRP
could	MD
detect	VB
a	DT
significant	JJ
amount	NN
of	IN
P-III-P	NN
(	(
2.2	CD
+	CC
/	:
-	:
1.0	CD
U/ml	NN
;	:
range	NN
0.03	CD
to	TO
16.5	CD
U/ml	NN
)	)
in	IN
BALF	NN
in	IN
18	CD
of	IN
the	DT
patients	NNS
(	(
5F	NN
and	CC
13M	NN
,	,
58	CD
+	CC
/	:
-	:
3	CD
years	NNS
)	)
(	(
group	NN
B	NN
)	)
.	.

but	CC
not	RB
(	(
0.03	CD
U/ml	NN
or	CC
less	JJR
)	)
in	IN
the	DT
other	JJ
30	CD
patients	NNS
(	(
11F	NN
and	CC
19M	NN
,	,
59	CD
+	CC
/	:
-	:
2	CD
years	NNS
)	)
(	(
group	NN
A	NN
)	)
.	.

Lymphocyte	NN
(	(
%	NN
)	)
and	CC
basophil	NN
(	(
%	NN
)	)
in	IN
BALF	NN
from	IN
group	NN
B	NN
was	VBD
much	RB
larger	JJR
than	IN
that	DT
from	IN
group	NN
A	NN
(	(
33	CD
%	NN
vs.	CC
8	CD
%	NN
,	,
p	NN
<	JJR
0.01	CD
)	)
.	.

Group	NN
B	NN
showed	VBD
a	DT
longer	RBR
duration	NN
of	IN
onset	NN
to	TO
BAL	NN
(	(
36	CD
months	NNS
vs.	CC
23	CD
months	NNS
,	,
p	NN
<	JJR
0.05	CD
)	)
.	.

TGF-beta	NN
levels	NNS
were	VBD
obtained	VBN
using	VBG
an	DT
ELISA	NN
system	NN
kit	NN
from	IN
the	DT
same	JJ
BALF	NN
samples	NNS
.	.

TGF-beta	NN
was	VBD
not	RB
detected	VBN
in	IN
10	CD
patients	NNS
(	(
100	CD
pg/ml	NN
or	CC
less	JJR
)	)
(	(
3F	NN
and	CC
7M	NN
,	,
59	CD
+	CC
/	:
-	:
4	CD
years	NNS
)	)
(	(
group	NN
I	CD
)	)
,	,
while	IN
the	DT
remaining	VBG
38	CD
patients	NNS
showed	VBD
a	DT
significant	JJ
amount	NN
of	IN
TGF-beta	NN
(	(
329	CD
+	CC
/	:
-	:
44	CD
pg/ml	NN
,	,
range	NN
100	CD
to	TO
1,360	CD
pg/ml	NN
)	)
.	.

The	DT
latter	JJ
patients	NNS
were	VBD
further	JJ
divided	VBN
into	IN
two	CD
groups	NNS
;	:
group	NN
II	CD
100	CD
to	TO
300	CD
pg/ml	NN
(	(
10F	NN
and	CC
14M	NN
,	,
56	CD
+	CC
/	:
-	:
3	CD
years	NNS
)	)
and	CC
group	NN
III	CD
350	CD
or	CC
more	JJR
(	(
3F	NN
and	CC
11M	NN
,	,
63	CD
+	CC
/	:
-	:
2	CD
years	NNS
)	)
.	.

Group	NNP
III	NNP
showed	VBD
significantly	RB
better	JJR
values	NNS
in	IN
PaO2	NN
,	,
Aa-DO2	NN
,	,
%	NN
VC	NN
and	CC
%	NN
DLco	NN
,	,
and	CC
smaller	JJR
percentage	NN
of	IN
basophils	NNS
in	IN
BALF	NN
than	IN
did	VBD
groups	NNS
I	PRP
and/or	CC
II	CD
,	,
whereas	IN
survival	NN
after	IN
BAL	NN
in	IN
group	NN
III	CD
was	VBD
significantly	RB
shorter	JJR
than	IN
in	IN
group	NN
I	CD
(	(
31	CD
vs.	CC
19	CD
months	NNS
,	,
p	NN
<	JJR
0.05	CD
)	)
.	.

There	EX
was	VBD
no	DT
significant	JJ
relationship	NN
between	IN
P-III-P	NN
and	CC
TGF-beta	NN
levels	NNS
in	IN
BALF	NN
.	.

These	DT
findings	NNS
suggest	VBP
that	IN
elevated	JJ
P-III-P	NN
level	NN
is	VBZ
accompanied	VBN
by	IN
an	DT
increase	NN
in	IN
lymphocyte	NN
population	NN
in	IN
BALF	NN
from	IN
IPF	NN
patients	NNS
,	,
resulting	VBG
in	IN
a	DT
longer	RBR
duration	NN
of	IN
the	DT
disease	NN
,	,
while	IN
elevated	JJ
TGF-beta	NN
level	NN
reflects	VBZ
alveolar	JJ
inflammation	NN
at	IN
an	DT
earlier	JJR
stage	NN
of	IN
the	DT
disease	NN
which	WDT
induces	VBZ
a	DT
progression	NN
of	IN
the	DT
disease	NN
,	,
resulting	VBG
in	IN
a	DT
shorter	JJR
survival	NN
in	IN
IPF	NN
patients	NNS
.	.

